vs
Encompass Health Corp（EHC）とRithm Capital Corp.（RITM）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $828.2M、Rithm Capital Corp.の約1.9倍）。Rithm Capital Corp.の純利益率が高く（13.2% vs 9.5%、差は3.8%）。Rithm Capital Corp.の前年同期比売上増加率が高い（508.5% vs 9.9%）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs -17.9%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
Rithm Capital Corp.はアメリカ合衆国ニューヨークに本社を置く投資運用会社で、不動産投資とオルタナティブ投資を主力事業としています。専門的な投資調査チームと豊富な市場経験を基に、投資家に長期的かつ安定したリターンの提供を目指しています。
EHC vs RITM — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $828.2M |
| 純利益 | $146.1M | $109.5M |
| 粗利率 | — | — |
| 営業利益率 | 16.7% | 29.9% |
| 純利益率 | 9.5% | 13.2% |
| 売上前年比 | 9.9% | 508.5% |
| 純利益前年比 | 20.8% | 27.7% |
| EPS（希薄化後） | $1.43 | $0.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | — | $828.2M | ||
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.5B | $1.1B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.5B | $768.4M | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.4B | $619.5M | ||
| Q2 24 | $1.3B | $1.2B |
| Q1 26 | — | $109.5M | ||
| Q4 25 | $146.1M | $85.0M | ||
| Q3 25 | $126.5M | $221.5M | ||
| Q2 25 | $142.1M | $311.7M | ||
| Q1 25 | $151.5M | $78.8M | ||
| Q4 24 | $120.9M | $290.2M | ||
| Q3 24 | $108.2M | $121.7M | ||
| Q2 24 | $114.1M | $235.6M |
| Q1 26 | — | 29.9% | ||
| Q4 25 | 16.7% | 13.8% | ||
| Q3 25 | 14.9% | 21.4% | ||
| Q2 25 | 16.2% | 25.2% | ||
| Q1 25 | 16.4% | 7.4% | ||
| Q4 24 | 14.3% | 23.8% | ||
| Q3 24 | 13.6% | 7.3% | ||
| Q2 24 | 14.3% | 23.6% |
| Q1 26 | — | 13.2% | ||
| Q4 25 | 9.5% | 5.7% | ||
| Q3 25 | 8.6% | 20.0% | ||
| Q2 25 | 9.7% | 25.6% | ||
| Q1 25 | 10.4% | 10.3% | ||
| Q4 24 | 8.6% | 14.0% | ||
| Q3 24 | 8.0% | 19.7% | ||
| Q2 24 | 8.8% | 19.2% |
| Q1 26 | — | $0.12 | ||
| Q4 25 | $1.43 | $0.09 | ||
| Q3 25 | $1.24 | $0.35 | ||
| Q2 25 | $1.39 | $0.53 | ||
| Q1 25 | $1.48 | $0.07 | ||
| Q4 24 | $1.18 | $0.50 | ||
| Q3 24 | $1.06 | $0.20 | ||
| Q2 24 | $1.12 | $0.43 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | — |
| 総負債低いほど良い | $2.4B | — |
| 株主資本純資産 | $2.4B | $9.1B |
| 総資産 | $7.1B | $53.4B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | — | ||
| Q4 25 | $72.2M | $1.8B | ||
| Q3 25 | $48.7M | $1.6B | ||
| Q2 25 | $99.1M | $1.6B | ||
| Q1 25 | $95.8M | $1.5B | ||
| Q4 24 | $85.4M | $1.5B | ||
| Q3 24 | $147.8M | $1.6B | ||
| Q2 24 | $154.4M | $1.2B |
| Q1 26 | — | — | ||
| Q4 25 | $2.4B | $35.4B | ||
| Q3 25 | $2.4B | $32.2B | ||
| Q2 25 | $2.3B | $31.2B | ||
| Q1 25 | $2.3B | $32.2B | ||
| Q4 24 | $2.4B | $32.6B | ||
| Q3 24 | $2.3B | $29.6B | ||
| Q2 24 | $2.7B | $30.1B |
| Q1 26 | — | $9.1B | ||
| Q4 25 | $2.4B | $8.4B | ||
| Q3 25 | $2.4B | $8.5B | ||
| Q2 25 | $2.3B | $7.9B | ||
| Q1 25 | $2.2B | $7.8B | ||
| Q4 24 | $2.1B | $7.8B | ||
| Q3 24 | $2.0B | $7.7B | ||
| Q2 24 | $1.8B | $7.3B |
| Q1 26 | — | $53.4B | ||
| Q4 25 | $7.1B | $53.1B | ||
| Q3 25 | $6.9B | $47.2B | ||
| Q2 25 | $6.8B | $44.3B | ||
| Q1 25 | $6.6B | $45.3B | ||
| Q4 24 | $6.5B | $46.0B | ||
| Q3 24 | $6.5B | $42.3B | ||
| Q2 24 | $6.4B | $42.0B |
| Q1 26 | — | — | ||
| Q4 25 | 1.00× | 4.20× | ||
| Q3 25 | 1.01× | 3.79× | ||
| Q2 25 | 1.02× | 3.92× | ||
| Q1 25 | 1.08× | 4.14× | ||
| Q4 24 | 1.14× | 4.18× | ||
| Q3 24 | 1.20× | 3.87× | ||
| Q2 24 | 1.46× | 4.10× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | — |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | — |
| FCFマージンFCF / 売上 | 7.6% | — |
| 設備投資強度設備投資 / 売上 | 14.8% | — |
| キャッシュ転換率営業CF / 純利益 | 2.37× | — |
| 直近12ヶ月FCF直近4四半期 | $439.2M | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | — | ||
| Q4 25 | $346.0M | $-114.6M | ||
| Q3 25 | $270.8M | $-2.0B | ||
| Q2 25 | $270.2M | $-557.1M | ||
| Q1 25 | $288.6M | $1.4B | ||
| Q4 24 | $278.8M | $-1.8B | ||
| Q3 24 | $267.8M | $768.1M | ||
| Q2 24 | $217.4M | $-55.7M |
| Q1 26 | — | — | ||
| Q4 25 | $116.7M | — | ||
| Q3 25 | $83.7M | — | ||
| Q2 25 | $113.3M | — | ||
| Q1 25 | $125.5M | — | ||
| Q4 24 | $80.1M | — | ||
| Q3 24 | $120.3M | — | ||
| Q2 24 | $60.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 8.6% | — | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 4.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 14.8% | — | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 14.1% | — | ||
| Q3 24 | 10.9% | — | ||
| Q2 24 | 12.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.37× | -1.35× | ||
| Q3 25 | 2.14× | -9.22× | ||
| Q2 25 | 1.90× | -1.79× | ||
| Q1 25 | 1.90× | 18.03× | ||
| Q4 24 | 2.31× | -6.04× | ||
| Q3 24 | 2.48× | 6.31× | ||
| Q2 24 | 1.91× | -0.24× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
RITM
| Servicing revenue, net | $375.1M | 45% |
| Other | $234.9M | 28% |
| Gain on originated residential mortgage loans, held-for-sale, net | $195.0M | 24% |
| Other revenue | $23.3M | 3% |
